Every treatment we track, side by side. Same information, same order, every time.
encorafenib/binimetinib
BRAF/MEK targeted therapy for selected melanoma and other contexts
dabrafenib/trametinib
BRAF/MEK targeted therapy for selected melanoma, NSCLC, thyroid and other contexts